急性早幼粒细胞白血病的转录组图谱揭示血小板聚集激动剂Podoplanin的异常表面表达
该研究对30例急性早幼粒细胞白血病(APL)进行RNA测序,并与400例其他急性髓系白血病及正常早幼粒细胞比较。发现PDPN基因在APL早幼粒细胞中异常表达,是APL最特异的表面标志物,全反式维甲酸可快速降低其表达。功能实验表明PDPN可诱导血小板结合、活化和聚集,异种移植模型中PDPN表达与血小板减少和出血时间延长相关。
要点
- PDPN是APL最特异的表面标志物,全反式维甲酸治疗可快速降低其表达。
- PDPN在APL早幼粒细胞中异常表达,是APL最具鉴别性的转录本。
- PDPN表达的原代APL细胞可特异性诱导血小板结合、活化和聚集。
核心结论
- 研究结果提示PDPN可能参与APL中发现的止血功能紊乱。
研究设计与样本
- 基于RNA测序对30例APL进行转录组表征,并与400例其他急性髓系白血病样本及正常早幼粒细胞比较。
- 使用针对急性髓系白血病诊断优化的流式细胞术抗体组合检测PDPN表面表达。
- 功能研究:在人白血病细胞中工程化过表达PDPN,检测血小板结合、活化和聚集。
- 使用表达PDPN的原代APL细胞与PDPN阴性原代白血病细胞进行血小板功能实验。
- 在异种移植模型中评估白血病细胞PDPN表达与血小板减少及出血时间的关系。
主要发现
- APL转录组中凝血和纤溶相关基因的紊乱超越已知因素,包括凝血酶、因子X和尿激酶受体。
- PDPN基因在APL早幼粒细胞中异常表达,是该疾病最具鉴别性的转录本。
- PDPN是APL最特异的表面标志物,全反式维甲酸治疗可快速降低其表达。
- 工程化过表达PDPN的人白血病细胞引起异常血小板结合、活化和聚集。
- 表达PDPN的原代APL细胞而非PDPN阴性原代白血病细胞特异性诱导血小板结合、活化和聚集。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute promyelocytic leukemia (APL) is a medical emergency because of associated lethal early bleeding, a condition preventable by prompt diagnosis and therapeutic intervention. The mechanisms underlying the hemostatic anomalies of APL are not completely elucidated. RNA-sequencing-based characterization of APL (n = 30) was performed and compared to that of other acute myeloid leukemia (n = 400) samples and normal promyelocytes. Perturbations in the transcriptome of coagulation and fibrinolysis-related genes in APL extend beyond known culprits and now include Thrombin, Factor X and Urokinase Receptor. Most intriguingly, the Podoplanin (PDPN) gene, involved in platelet aggregation, is aberrantly expressed in APL promyelocytes and is the most distinctive transcript for this disease. Using an antibody panel optimized for AML diagnosis by flow cytometry, we also found that PDPN was the most specific surface marker for APL, and that all-trans retinoic acid therapy rapidly decreases its expression. Functional studies showed that engineered overexpression of this gene in human leukemic cells causes aberrant platelet binding, activation and aggregation. PDPN-expressing primary APL cells, but not PDPN-negative primary leukemias, specifically induce platelet binding, activation and aggregation. Finally, PDPN expression on leukemia cells in a xenograft model was associated with thrombocytopenia and prolonged bleeding time in vivo. Together our results suggest that PDPN may contribute to the hemostatic perturbations found in APL.
引用
- Lavallée VP, Chagraoui J, MacRae T, et al. Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin. Leukemia. 2018. PMID: 29550835. doi:10.1038/s41375-018-0069-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。